Research Research
TEA/AEE line — fidgets
Care starts with not promising what hasn’t been proven yet.
A sensory product cannot reach children, students, families or professionals just because the idea seems good. We halted any commercial path until safety, materials, legal, certification, educational-fit and specialist reviews are complete.
This page records research. There is no therapeutic, educational or safety promise, and there is no open offer.
Stage: In research and validation — requires safety, legal, educational and specialist review
OBOS in practice
How we are developing with criteria
This line’s first plan, from July 2026, went through self-criticism before becoming direction: we acknowledged incomplete research, untested commercial hypotheses and a safety treatment that merely “recommended caution” — language far too weak when the risk involves children. Since then, physical risk is a blocking prerequisite, not a side note.
The record also barred generalizations: no universal statements about autistic people, no popular percentages without verification, no partial scientific reference treated as proof of our product. The research moves through gates — approval checkpoints crossed one at a time — and sales stay closed until the last of them.
What we still need to prove
- Safety assessment and material suitability.
- Legal and certification review.
- Educational and specialist assessment.
- Without those approvals, sales stay closed.
This is how we work inside Órion itself: decisions with an owner and a date, named validations, and sales only after the criteria. OBOS is the system that organizes it from the inside.